Return-to-work support in cancer patients: Which methodology?
Laétitia Rollin1, Geraldine De Blasi2, Line Boucher3
1Centre hospitalo-universitaire de Rouen, service de médecine du travail et pathologie professionnelle, Rouen, France; Rouen University, Sorbonne university, university of Paris 13, laboratory of medical informatics and knowledge engineering in e-Health, LIMICS, Inserm, 75006 Paris, France.
Bulletin Du Cancer
|December 23, 2019
Summary
Returning to work after cancer improves quality of life. Individual psychological support and company physician consultations significantly aid cancer patients
Area of Science:
- Oncology
- Occupational Health
- Psychology
Background:
- Return to work is crucial for cancer patients' quality of life.
- Cancer survivorship presents challenges to employment.
- Multidisciplinary support is key for successful reintegration.
Purpose of the Study:
- To document return-to-work interventions used in a French hospital.
- To evaluate the effectiveness of these interventions on patient outcomes.
Main Methods:
- A questionnaire was administered to 153 patients.
- Patients received multidisciplinary support post-cancer.
- Data analyzed to determine return-to-work rates.
Main Results:
- 50% of patients returned to work within two years.
- Individual psychological support significantly increased return-to-work rates (P=0.04).
- Company physician consultations showed a positive, though not significant, trend (P=0.08).
Conclusions:
- Systematically recommend individual psychological support and company physician consultations.
- Support groups and handicapped worker status recognition should be individualized.
- Interventions should focus on personalized patient needs for return to work.
Related Concept Videos
Cancer Survival Analysis
609
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
609
Classification of Illness
8.4K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.4K
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
897
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
897

